Jubilant Biosys, a Bangalore-based subsidiary of Jubilant Organosys Ltd., has entered into a discovery and development collaboration with Endo Pharmaceuticals to develop a portfolio of oncology targets with a focus on delivering preclinical candidates for joint clinical development. Endo will own any compounds developed under the collaboration and will be responsible for worldwide commercialization. In the initial three-year agreement, Jubilant will receive research funding and success-based ...